Summary
In vitro T cell-mediated cytotoxic responses to tumor associated antigens or alloantigens can be augmented by the addition of small amounts (0.1 to 1%) of syngeneic (mouse) or xenogeneic (rabbit) serum in the standard lymphocyte culture medium. Further studies showed that the augmentation is mediated by helper cells, which are induced by culturing the spleen cells or lymph node cells in the presence of these sera. In the syngeneic system performed with mixed lymphocyte tumor cell cultures (MLTC), the serum-induced helper cells are found to be resistant to the lysis of anti-Thy 1.2 antibody and are radioresistant; thus they have the characteristics of macrophages. In the allogeneic system performed with mixed lymphocyte culture (MLC), the serum-induced helper cells are also found to be resistant to the lysis of anti-Thy 1.2 antibody but are radiosensitive. In the latter case, however, removal of T cells abolishes the helper cell generation and only the T cell-enriched fraction provides for the generation of helper cells, indicating that the helper cells for MLC are probably derived from T cells but lose their susceptibility to anti-Thy 1.2 antibody lysis upon culturing in vitro. A study of the mode of action of the helper cells for MLC showed that they are probably needed at a later stage of cytotoxic response for the amplification of the killing efficiency of the T effector cells whereas the helper cells for MLTC are needed in the early induction phase of the immune response. These results indicate that although serum can augment the cytotoxic responses both in the syngeneic and in the allogeneic systems, the mechanism for the augmentation differs: macrophagelike helper cells are responsible for the augmentation of cytotoxic response to tumor associated antigens, whereas augmentation of cytotoxic response to alloantigens appears to be mediated by a subpopulation of T helper cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cerottini, J. C.; Engers, H. D.; MacDonald, H. R.; Brunner, K. T. Generation of cytotoxic T lymphocyte in vitro. I. Response of normal and immune mouse spleen cells in mixed lymphocyte cultures. J. Exp. Med. 140: 703–717; 1974.
Ting, C. C.; Bonnard, G. D. Cell-mediated immunity to Friend virus-induced leukemia. IV. In vitro generation of primary and secondary cell-mediated cytotoxic responses. J. Immunol. 116: 1419–1425; 1976.
Ting, C. C. Studies of the mechanisms for the induction of in vivo tumor immunity. I. Induction of primary and secondary cell-mediated cytotoxic responses by adoptice transfer of lymphocytes. Cell Immunol. 27: 71–81; 1976.
Ting, C. C.; Rodrigues. D.; Igarashi, T. Studies of the mechanisms for the induction of in vivo tumor immunity. III. Recruitment of host helper cells by donor T cells in adoptive transfer of cell-mediated immunity. J. Immunol. 122: 1510–1518; 1979.
Nabholz, M.; Vives, J.; Young, H. M.; Miggiano, V.; Rijnbeck, A.; Schreffler, D. C. Cell-mediated lysisin vitro; genetic control of killer cell production and target specificities in the mouse. Eur. J. Immunol. 4: 378–387; 1974.
Mage, M.; McHugh, L. L.; Rothstein, T. L. Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin. J. Immunol. Methods 15: 47–56; 1977.
Julius, M. H.; Simpson, E.; Herzenberg, L. A. A rapid method for the isolation of functional thymus derived murine lymphocytes. Eur. J. Immunol. 3: 645–649; 1973.
Ting, C. C.; Bushar, G. S.; Rodrigues, D.; Herberman, R. B. Cell-mediated immunity to Friend virus-induced leukemia. I. Modification of125IUdR release cytotoxicity assay for use with suspension target cells. J. Immunol. 115: 1351–1356; 1975.
Glynn, J. P.; McCoy, J. L.; Fefer, A. Cross-resistance to the transplantation of syngeneic Friend, Moloney, and Rauscher virus-induced tumors. Cancer Res. 28: 434–439; 1968.
Freedman, H. A.; Lilly, F. Properties of cell lines derived from tumors induced by Friend virus in BALB/c and BALB/c-H-2b mice. J. Exp. Med. 142: 212–223; 1975.
Gorer, P. A. Studies in antibody response of mice to tumor inoculation. Brit. J. Cancer 4: 372–379; 1950.
Reif, A. E.; Allen, J. M. V. The AKR thymic antigen and its distribution in leukemia and nervous tissue. J. Exp. Med. 120: 413–433; 1964.
Herberman, R. B.; Nunn, M. E.; Lavrin, D. H.; Asofsky, R. J. Effect of antibody to antigens on cell-mediated immunity induced in syngeneic mice by murine sarcoma virus. J. Natl. Cancer Inst. 51: 1509–1512; 1973.
Hodes, R. J.; Hathcock, K. S. In vitro generation of suppressor cell activity: suppression ofin vitro induction of cell-mediated cytotoxicity. J. Immunol. 116: 167–177; 1976.
Igarashi, T.; Rodrigues, D.; Ting, C. C. Studies of the mechanisms for the induction ofin vivo tumor immunity. IV. Enhancement of thein vitro generation of secondary cell-mediated cytotoxic response by normal peritoneal macrophages and their culture supernatants. J. Immunol. 122: 1519–1527; 1979.
Ting, C. C.; Rodrigues, D. Reversal by peritoneal adherent cells of tumor cell suppression of T cell-mediated immunity. J. Immunol. 123: 801–807; 1979.
Pierce, C. W. Immune responsein vitro. VII. Loss of susceptibility of functional-bearing cells to cytotoxic action of anti-serum and complementin vitro. Cell. Immunol. 9: 465–473; 1973.
Cantor, H.; Boyse, E. A. Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity. J. Exp. Med. 141: 1390–1399; 1975.
Author information
Authors and Affiliations
Additional information
Supported by a grant from the Japan Society for the Promotion of Science (T. I.).
Rights and permissions
About this article
Cite this article
Ting, C.C., Natori, T., Igarashi, T. et al. Augmentation by serum-induced helper cells of T cell-mediated cytotoxic response against tumor associated antigens and alloantigens. In Vitro 16, 781–790 (1980). https://doi.org/10.1007/BF02619313
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02619313